angioplasty

I CURSO REGIONAL DE INTERVENCIONISMO PARA EL CARDIOLOGO CLINICO

Regional Course of Interventionism for the Clinical Cardiologist | with SOLACI’s Support

On November 30, 2019, the “I Regional Course of Interventionism for the Clinical Cardiologist” will take place in Chiclayo, Peru. The event will be held in the Muchick Room at Costa del Sol Hotel, organized by the Peruvian Society of Hemodynamics and Endovascular Interventionism (SOPHIE) with the support of SOLACI. The activity will be oriented to<a href="https://solaci.org/en/2019/11/13/regional-course-of-interventionism-for-the-clinical-cardiologist-with-solacis-support/" title="Read more" >...</a>

¿La elevación de marcadores luego de una angioplastia electiva no debería preocuparnos?

Should Post-PCI Biomarkers Elevation Be of Concern?

Elevated markers after PCI in stable patients treated with the latest generation stents continues to happen. However, only the association between biomarker elevation with creatine kinase-myocardial band (CK-MB) should be of concern, sin it was associated with mortality at one year. Post procedural cardiac troponin (cTn) elevation was not associated to future events, according to<a href="https://solaci.org/en/2019/11/11/should-post-pci-biomarkers-elevation-be-of-concern/" title="Read more" >...</a>

The Most Read Scientific Articles in Interventional Cardiology of October

The Most Read Scientific Articles of October in Interventional Cardiology

1- Incidence and Prognosis of Heart Valve Embolization The incidence of peri-procedural transcatheter heart valve embolization and migration (TVEM) is as low as 1%. However, it is associated with increased morbidity and mortality. Read more HERE 2- 1000 MitraClips: Results from the World’s Most Experienced Site In September 2008, interventional physicians at the Heart and<a href="https://solaci.org/en/2019/11/07/the-most-read-scientific-articles-of-october-in-interventional-cardiology/" title="Read more" >...</a>

¿Se debe tener en cuenta el género para revascularizar el tronco?

iFR or FFR Measurements by Sex: Is Either One More Adequate?

According to the post hoc analysis of the DEFINE-FLAIR, patient sex seems to affect instantaneous wave-free ratio (iFR) and fractional flow reserve (FFR) guided revascularization outcomes. Even though this is not specified in the study protocols, it might affect the gold standard for functional lesion assessment.  However, clinical outcomes are similar with both strategies. Therefore,<a href="https://solaci.org/en/2019/11/04/ifr-or-ffr-measurements-by-sex-is-either-one-more-adequate/" title="Read more" >...</a>

Seguridad de los balones con paclitaxel en enfermedad vascular periférica

Safety of Paclitaxel-Coated Balloons in Peripheral Vascular Disease

Everybody keeps wondering whether drug-coated balloons can actually increase mortality. If that is the case, there is an even harder question in need of an answer: what would be the physiopathology for such increase in mortality? As a lukewarm message, the US Food and Drug Administration recommended a special informed consent form when these devices<a href="https://solaci.org/en/2019/10/22/safety-of-paclitaxel-coated-balloons-in-peripheral-vascular-disease/" title="Read more" >...</a>

Jornadas Panamá | Concurso de Jóvenes Cardiólogos

See the 2019 Panama Sessions presentations

The&nbsp;XXXIX Regional SOLACI&nbsp;Sessions in Panama were an extremely successful scientific event. Renowned specialists in hemodynamics from all over Latin America presented their works and shared their knowledge in an event characterized by the utmost respect and comradeship. That is the reason why we share below those presentations, thanking these professionals for their contribution to our<a href="https://solaci.org/en/2019/10/21/see-the-2019-panama-sessions-presentations/" title="Read more" >...</a>

Highlights TCT 2019

TCT 2019 | PCI in Stable CAD. Prior TAVR, with TAVR or Never?

Courtesy of SBHCI. This interesting study presented at TCT 2019 and simultaneously published in Am J Cardiol tells us PCI in stable coronary artery disease cannot lower risk in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement (TAVR). Unless patients are symptomatic, most coronary artery lesions do not need revascularization according to researchers.<a href="https://solaci.org/en/2019/10/10/tct-2019-pci-in-stable-cad-prior-tavr-with-tavr-or-never/" title="Read more" >...</a>

Highlights TCT 2019

TCT 2019 | AUGUSTUS ACS: Apixaban vs. Warfarin and Aspirin vs. Placebo in AF and ACS

Courtesy of SBHCI. The safety and efficacy of antithrombotic and antiplatelet treatments in patients with atrial fibrillation admitted with acute coronary syndrome (who receive medical treatment or angioplasty) may vary from that in patients undergoing elective treatment. At 14&nbsp;days from elective angioplasty or hospitalization due to acute coronary syndrome, patients were randomized in a 2×2<a href="https://solaci.org/en/2019/09/30/tct-2019-augustus-acs-apixaban-vs-warfarin-and-aspirin-vs-placebo-in-af-and-acs/" title="Read more" >...</a>

Highlights TCT 2019

TCT 2019 | Onyx ONE: Durable Polymer vs. Polymer-Free Stent with Only One Month of Dual Antiplatelet Therapy

Courtesy of the SBHCI. This is the first randomized study comparing a durable-polymer drug-eluting stent (zotarolimus-eluting stent Onyx) and a polymer-free drug-eluting stent (biolimus-A9-coated stent BioFreedom), with only one month of dual antiplatelet therapy in patients at high risk for bleeding. Onyx ONE was a study conducted at 84&nbsp;sites that randomized 1:1 2000&nbsp;total patients at<a href="https://solaci.org/en/2019/09/30/tct-2019-onyx-one-durable-polymer-vs-polymer-free-stent-with-only-one-month-of-dual-antiplatelet-therapy/" title="Read more" >...</a>

Tasa de stroke post cirugía vs angioplastia coronaria en un análisis de más de 10.000 pacientes

Best Conduits and Best Surgeons for the Best Outcome

Myocardial revascularization surgery is still one of the most effective treatment strategies against coronary disease. One of the most important advantages of surgery over angioplasty is the chance to reach complete revascularization. This has proven to improve the survival of patients and to reduce the number of cardiovascular events. The choice of conduit for the<a href="https://solaci.org/en/2019/09/26/best-conduits-and-best-surgeons-for-the-best-outcome/" title="Read more" >...</a>

Top